Cushman & Wakefield: U.S. Life Sciences Market Moves Toward Rebalancing as Capital Returns and New Development Slows

Go back to Cushman & Wakefield: U.S. Life Sciences Market Moves Toward Rebalancing as Capital Returns and New Development Slows
(NYSE: CWK) Delayed: 12.40 -0.09 (0.72%)
Previous Close $12.49    52 Week High
Open $12.40    52 Week Low
Day High $12.55    P/E N/A 
Day Low $12.26    EPS
Volume 2,918,873